High-level STING expression in tumour and inflammatory cells is linked to microsatellite instability and favourable tumour parameters in a cohort of over 1,900 colorectal cancer patients.

The stimulator of interferon genes (STING) is expressed on various cell types and tumour entities, where it might enhance antitumoural effects of the immune system and impact tumour angiogenesis. However, the clinical significance of STING expression in tumour cells as compared to tumour-associated inflammatory cells is not fully resolved. To evaluate the clinical significance of STING expression in different cell types of colorectal cancer (CRC), 1,905 patients were analysed by multiplex fluorescence immunohistochemistry in a tissue microarray format in combination with a deep learning algorithm for automated cell detection. High STING expression on tumour was associated with microsatellite instability (MSI, p<0.0001), low tumour stage (pT, p=0.0013), absence of nodal metastasis (pN, p=0.0003) and tumour localisation in the right colon (p<0.0001). Subgroup analysis of tumours with and without MSI did not show associations between STING expression on tumour cells and pT or pN. While the number of CD68- leukocytes and macrophages was related to MSI, low pT ​and pN0, there were significant associations between a high percentage of STING-positive macrophages and CD68- leukocytes to low pT (p<0.0001 each) and the absence of metastases for a high percentage of STING-positive macrophages (p=0.0033). In summary, our data show that high STING expression in tumour cells is strongly linked to MSI while STING expression on macrophages and CD68- leukocytes is tightly linked to the extent of tumour-associated inflammation in CRC.

• Publication year

  2025

• Venue

  Pathology (Sydney)

• Publication date

  2025-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pathol.2025.05.008PMID 40816937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors

  2024cited by this paper
• Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities

  2024cited by this paper
• Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.

  2024cited by this paper
• Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry

  2023cited by this paper
• BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration

  2023cited by this paper
• Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation

  2023cited by this paper
• Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer

  2022cited by this paper
• Activation of cGAS-STING Pathway Is Associated with MSI-H Stage IV Colorectal Cancer

  2022cited by this paper
• [Expression of the cGAS-STING Pathway in dMMR/MSI-H in Colorectal Cancer].

  2022cited by this paper
• The immune phenotypes and different immune escape mechanisms in colorectal cancer

  2022cited by this paper
• Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer

  2022cited by this paper
• Discordance in STING-Induced Activation and Cell Death Between Mouse and Human Dendritic Cell Populations

  2022cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.

  2021cited by this paper
• Endothelial STING controls T cell transmigration in an IFNI-dependent manner

  2021cited by this paper
• STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

  2021cited by this paper
• E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors

  2021cited by this paper
• Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

  2021cited by this paper
• Key biomarkers within the colorectal cancer related inflammatory microenvironment

  2020cited by this paper
• Mutant p53 suppresses innate immune signaling to promote tumorigenesis

  2020cited by this paper
• Trial watch: STING agonists in cancer therapy

  2020cited by this paper
• STING signaling is a potential immunotherapeutic target in colorectal cancer

  2019cited by this paper
• Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans.

  2019cited by this paper
• STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.

  2019cited by this paper
• Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.

  2019cited by this paper
• Expression of STING and PD-L1 in colorectal cancer and their correlation with clinical prognosis.

  2018cited by this paper
• Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.

  2018cited by this paper
• Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs

  2018cited by this paper
• Mitotic progression following DNA damage enables pattern recognition within micronuclei

  2017cited by this paper
• Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes

  2017cited by this paper
• Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.

  2016cited by this paper
• Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer

  2016cited by this paper
• Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis.

  2016cited by this paper
• Comparative epigenomics in distantly related teleost species identifies conserved cis-regulatory nodes active during the vertebrate phylotypic period

  2014cited by this paper
• Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP

  2013cited by this paper
• Interferon-γ and Granulocyte/Monocyte Colony-stimulating Factor Production by Natural Killer Cells Involves Different Signaling Pathways and the Adaptor Stimulator of Interferon Genes (STING)

  2013cited by this paper
• Microsatellite instability in colorectal cancer.

  2010cited by this paper
• Microsatellite instability in colorectal cancer—the stable evidence

  2010cited by this paper
• STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling

  2008cited by this paper
• Tissue microarray: An effective high-throughput method to study the placenta for clinical and research purposes

  2006cited by this paper
• Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000

  2005cited by this paper
• Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

  2005cited by this paper
• Loss of antigenicity in stored sections of breast cancer tissue microarrays.

  2004cited by this paper
• Tissue microarrays.

  2004cited by this paper
• Tissue Microarrays: A Powerful Tool for High-Throughput Analysis of Clinical Specimens: A Review of the Method With Validation Data

  2002cited by this paper
• Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

  2001cited by this paper
• Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies

  2001cited by this paper
• More than one way to die: apoptosis, necrosis and reactive oxygen damage

  1999cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper

• No citing papers are available for this paper.